Mirum Pharmaceuticals Inc’s filing revealed that its Director Heron Patrick J acquired Company’s shares for reported $4301.0 on Sep 18 ’24. In the deal valued at $37.40 per share,115 shares were bought. As a result of this transaction, Heron Patrick J now holds 162,308 shares worth roughly $6.51 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Heron Patrick J bought 230 shares, generating $9,563 in total proceeds. Upon buying the shares at $41.58, the Director now owns 162,193 shares.
Before that, Howe Jolanda sold 375 shares. Mirum Pharmaceuticals Inc shares valued at $12,750 were divested by the SVP, GLOBAL CONTROLLER at a price of $34.00 per share. As a result of the transaction, Howe Jolanda now holds 2,426 shares, worth roughly $97331.12.
Stifel initiated its Mirum Pharmaceuticals Inc [MIRM] rating to a Buy in a research note published on April 17, 2024; the price target was $48. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in mid December has reiterated a ‘”a Buy”‘ rating for it. Morgan Stanley started covering the stock on November 13, 2023. It rated MIRM as “an Overweight”.
Price Performance Review of MIRM
On Tuesday, Mirum Pharmaceuticals Inc [NASDAQ:MIRM] saw its stock jump 2.87% to $40.12. Over the last five days, the stock has gained 2.92%. Mirum Pharmaceuticals Inc shares have risen nearly 35.91% since the year began. Nevertheless, the stocks have risen 26.96% over the past one year. While a 52-week high of $45.23 was reached on 08/28/24, a 52-week low of $23.14 was recorded on 04/25/24. SMA at 50 days reached $40.74, while 200 days put it at $31.32.
Levels Of Support And Resistance For MIRM Stock
The 24-hour chart illustrates a support level at 38.59, which if violated will result in even more drops to 37.06. On the upside, there is a resistance level at 41.10. A further resistance level may holdings at 42.08. The Relative Strength Index (RSI) on the 14-day chart is 50.76, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 39.44%. Stochastics %K at 44.65% indicates the stock is a holding.
How much short interest is there in Mirum Pharmaceuticals Inc?
A steep rise in short interest was recorded in Mirum Pharmaceuticals Inc stocks on 2024-09-13, growing by 0.18 million shares to a total of 7.05 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 6.87 million shares. There was a rise of 2.54%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 24, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $50 price target.
